Correlation Between ALRN Old and Histogen
Can any of the company-specific risk be diversified away by investing in both ALRN Old and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ALRN Old and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ALRN Old and Histogen, you can compare the effects of market volatilities on ALRN Old and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ALRN Old with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of ALRN Old and Histogen.
Diversification Opportunities for ALRN Old and Histogen
Pay attention - limited upside
The 3 months correlation between ALRN and Histogen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ALRN Old and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and ALRN Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ALRN Old are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of ALRN Old i.e., ALRN Old and Histogen go up and down completely randomly.
Pair Corralation between ALRN Old and Histogen
If you would invest 2.60 in Histogen on December 30, 2024 and sell it today you would earn a total of 0.10 from holding Histogen or generate 3.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
ALRN Old vs. Histogen
Performance |
Timeline |
ALRN Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Histogen |
Risk-Adjusted Performance
Modest
Weak | Strong |
ALRN Old and Histogen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ALRN Old and Histogen
The main advantage of trading using opposite ALRN Old and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ALRN Old position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.ALRN Old vs. Benitec Biopharma Ltd | ALRN Old vs. Artelo Biosciences | ALRN Old vs. Curis Inc | ALRN Old vs. ABVC Biopharma |
Histogen vs. Virax Biolabs Group | Histogen vs. Artelo Biosciences | Histogen vs. Curis Inc | Histogen vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Fundamental Analysis View fundamental data based on most recent published financial statements |